Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methanococcus maripaludis DNA-directed RNA polymerase subunit H (rpoH) CSB-YP411093MNR
CSB-EP411093MNR
CSB-BP411093MNR
CSB-MP411093MNR
CSB-EP411093MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Elongation factor 1-alpha (tuf) CSB-YP411094MNR
CSB-EP411094MNR
CSB-BP411094MNR
CSB-MP411094MNR
CSB-EP411094MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis 50S ribosomal protein L24P (rpl24p) CSB-YP411095MNR
CSB-EP411095MNR
CSB-BP411095MNR
CSB-MP411095MNR
CSB-EP411095MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis 30S ribosomal protein S8P (rps8p) CSB-YP411096MNR
CSB-EP411096MNR
CSB-BP411096MNR
CSB-MP411096MNR
CSB-EP411096MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis 50S ribosomal protein L30P (rpl30p) CSB-YP411097MNR
CSB-EP411097MNR
CSB-BP411097MNR
CSB-MP411097MNR
CSB-EP411097MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (apgM) CSB-YP411098MNR
CSB-EP411098MNR
CSB-BP411098MNR
CSB-MP411098MNR
CSB-EP411098MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis 5-methylthioadenosine/S-adenosylhomocysteine deaminase (mtaD) CSB-YP411099MNR
CSB-EP411099MNR
CSB-BP411099MNR
CSB-MP411099MNR
CSB-EP411099MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis 50S ribosomal protein L4P (rpl4p) CSB-YP411100MNR
CSB-EP411100MNR
CSB-BP411100MNR
CSB-MP411100MNR
CSB-EP411100MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Tetrahydromethanopterin S-methyltransferase subunit A (mtrA), partial CSB-YP411101MNR
CSB-EP411101MNR
CSB-BP411101MNR
CSB-MP411101MNR
CSB-EP411101MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Proteasome-activating nucleotidase (pan) CSB-YP411102MNR
CSB-EP411102MNR
CSB-BP411102MNR
CSB-MP411102MNR
CSB-EP411102MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Probable tRNA pseudouridine synthase B (truB) CSB-YP411103MNR
CSB-EP411103MNR
CSB-BP411103MNR
CSB-MP411103MNR
CSB-EP411103MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP411104MNR
CSB-EP411104MNR
CSB-BP411104MNR
CSB-MP411104MNR
CSB-EP411104MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Probable DNA primase small subunit (priA) CSB-YP411105MNR
CSB-EP411105MNR
CSB-BP411105MNR
CSB-MP411105MNR
CSB-EP411105MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis 2-phospho-L-lactate guanylyltransferase (cofC) CSB-YP411106MNR
CSB-EP411106MNR
CSB-BP411106MNR
CSB-MP411106MNR
CSB-EP411106MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Phosphoribosylformylglycinamidine synthase 1 (purQ) CSB-YP411107MNR
CSB-EP411107MNR
CSB-BP411107MNR
CSB-MP411107MNR
CSB-EP411107MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Prefoldin subunit beta (pfdB) CSB-YP411108MNR
CSB-EP411108MNR
CSB-BP411108MNR
CSB-MP411108MNR
CSB-EP411108MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Probable translation initiation factor IF-2 (infB), partial CSB-YP411109MNR
CSB-EP411109MNR
CSB-BP411109MNR
CSB-MP411109MNR
CSB-EP411109MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Shikimate kinase (aroK) CSB-YP411110MNR
CSB-EP411110MNR
CSB-BP411110MNR
CSB-MP411110MNR
CSB-EP411110MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Alanine--tRNA ligase (alaS), partial CSB-YP411111MNR
CSB-EP411111MNR
CSB-BP411111MNR
CSB-MP411111MNR
CSB-EP411111MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanococcus maripaludis Translation initiation factor 1A (eIF1A) CSB-YP411112MNR
CSB-EP411112MNR
CSB-BP411112MNR
CSB-MP411112MNR
CSB-EP411112MNR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>